Literature DB >> 1578230

Focal reductions of cerebral blood flow in amyotrophic lateral sclerosis: a [99mTc]-d,l-HMPAO SPECT study.

G Waldemar1, S Vorstrup, T S Jensen, A Johnsen, G Boysen.   

Abstract

We investigated regional cerebral blood flow (rCBF) using the [99mTc]-d,l-HMPAO technique with brain dedicated high resolution single photon emission computer tomography (SPECT) in 14 consecutive patients with amyotrophic lateral sclerosis (ALS), median age 62 years (45-77). Global CBF, expressed in % relative to the cerebellum, was significantly lower (P less than 0.05) in the ALS group (80.5 +/- 6.7%) than in the control group of 14 age-matched healthy volunteers (87.0 +/- 7.5%). Eight patients (57%) had abnormal rCBF distribution maps with reduced flow, primarily in the frontal lobes. Three of the 8 patients with abnormal rCBF had mild to moderate dementia and another one had mild aphasia. None of the patients with normal rCBF distribution maps had dementia. In the group of ALS patients as a whole rCBF was significantly reduced in the frontal cortex, the hippocampus, and the central white matter. We conclude that reduced rCBF, primarily in the frontal lobes, is a frequent finding in patients with ALS. The decreased rCBF may be associated with cognitive deficits and is most likely caused by neuronal degeneration and reduced metabolic needs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1578230     DOI: 10.1016/0022-510x(92)90204-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis.

Authors:  P J Massman; J Sims; N Cooke; L J Haverkamp; V Appel; S H Appel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

2.  Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.

Authors:  Kazunori Miyazaki; Kazuto Masamoto; Nobutoshi Morimoto; Tomoko Kurata; Takahumi Mimoto; Takayuki Obata; Iwao Kanno; Koji Abe
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-09       Impact factor: 6.200

Review 3.  Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.

Authors:  Stefanie M A Willekens; Donatienne Van Weehaeghe; Philip Van Damme; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-08       Impact factor: 9.236

4.  Flow-metabolism uncoupling in the cervical spinal cord of ALS patients.

Authors:  Toru Yamashita; Tetsuhiro Hatakeyama; Kota Sato; Yusuke Fukui; Nozomi Hishikawa; Yasuyuki Ohta; Yoshihiro Nishiyama; Nobuyuki Kawai; Takashi Tamiya; Koji Abe
Journal:  Neurol Sci       Date:  2017-01-24       Impact factor: 3.307

Review 5.  The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Authors:  Rachel L Redler; Nikolay V Dokholyan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 6.  Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.

Authors:  Pierre-François Pradat; Michel Dib
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 7.  VEGF: a critical player in neurodegeneration.

Authors:  Erik Storkebaum; Peter Carmeliet
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

8.  High resolution SPECT with [99mTc]-d,l-HMPAO in normal pressure hydrocephalus before and after shunt operation.

Authors:  G Waldemar; J F Schmidt; F Delecluse; A R Andersen; F Gjerris; O B Paulson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

9.  Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study.

Authors:  P R Talbot; P J Goulding; J J Lloyd; J S Snowden; D Neary; H J Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

Review 10.  Lessons of ALS imaging: Pitfalls and future directions - A critical review.

Authors:  Peter Bede; Orla Hardiman
Journal:  Neuroimage Clin       Date:  2014-02-27       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.